GLP1R and polycystic ovary syndrome: Additionally, some studies demonstrated improvements in hyperandrogenism, such as improved menstruation and reduction in hirsutism, as well as cystic morphology, such as a reduction in ovarian cysts, following pharmacological management of patients with PCOS with a GLP-1 receptor agonist [15,18,19,21].